National Headache Foundation Launches Primary Care Migraine Program

NEXT STORY
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PREV STORY
Tiziana Life Sciences plc – Interim Results for the Six Months Ended 30 June 2021
Subscribe to PM360
Print Subscription
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2017

TORONTO, ONTARIO--(Marketwired - Oct. 19, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") ...

author_avatar
NASDAQ Market News

Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors

AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage ...

author_avatar
NASDAQ Market News

Chembio Completes Acquisition of Malaysia-based RVR Diagnostics

MEDFORD, N.Y., Jan. 10, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News